Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Enovix (NASDAQ:ENVX) Stock Price Up 6.9% - Should You Buy?

Enovix logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s stock price was up 6.9% during mid-day trading on Wednesday. The stock traded as high as $2.39 and last traded at $2.4050. Approximately 1,949,566 shares traded hands during trading, a decline of 71% from the average daily volume of 6,821,366 shares. The stock had previously closed at $2.25.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ENVX. TD Cowen raised Enovix to a "hold" rating in a research report on Monday, October 5th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Enovix in a research report on Friday, October 2nd. Bank of America reissued a "neutral" rating and set a $5.00 price objective on shares of Enovix in a report on Monday, August 17th. Loop Capital upgraded Enovix to a "strong-buy" rating in a research report on Monday, August 17th. Finally, Canaccord Genuity Group lowered their price target on shares of Enovix from $15.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $10.77.

Read Our Latest Stock Report on Enovix

Enovix Trading Up 10.4%

The company has a 50 day moving average of $3.08 and a 200 day moving average of $4.98. The company has a current ratio of 9.71, a quick ratio of 9.37 and a debt-to-equity ratio of 2.46. The firm has a market cap of $545.33 million, a price-to-earnings ratio of -3.08 and a beta of 2.49.

Enovix (NASDAQ:ENVX - Get Free Report) last announced its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The firm had revenue of $9.02 million for the quarter, compared to analysts' expectations of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The business's revenue was up 20.8% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. As a group, research analysts anticipate that Enovix Corporation will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Enovix

A number of hedge funds have recently made changes to their positions in the company. Sax Wealth Advisors LLC acquired a new position in Enovix during the 3rd quarter worth about $29,000. Caitong International Asset Management Co. Ltd acquired a new stake in Enovix in the 4th quarter valued at about $30,000. Calamos Advisors LLC acquired a new stake in Enovix in the 1st quarter valued at about $60,000. Sequoia Financial Advisors LLC bought a new position in shares of Enovix in the second quarter worth about $61,000. Finally, Gateway Wealth Partners LLC bought a new position in shares of Enovix in the first quarter worth about $68,000. Institutional investors and hedge funds own 50.92% of the company's stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company's design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines